1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CIB1 CTRPv2 pan-cancer AAC -0.16 5e-06
mRNA HMGB1 CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA SMARCD1 CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA PTMA CTRPv2 pan-cancer AAC 0.17 5e-06
mRNA ABRACL CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA C9orf24 CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA CCNJ CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA IQGAP1 CTRPv2 pan-cancer AAC -0.16 5e-06
mRNA AVPI1 CTRPv2 pan-cancer AAC -0.16 5e-06
mRNA TRO CTRPv2 pan-cancer AAC 0.17 5e-06
Download CSV